Sign Up to like & get
recommendations!
2
Published in 2023 at "ACS nano"
DOI: 10.1021/acsnano.2c12217
Abstract: Administration of bispecific antibodies (biAbs) in tumor therapy is limited by their short half-life and off-target toxicity. Optimized strategies or targets are needed to overcome these barriers. B7-H3 (CD276), a member of the B7 superfamily,…
read more here.
Keywords:
degcg nps;
biab degcg;
ferroptosis;
degcg ... See more keywords